The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Rabin, Joel Stewart
    Director born in February 1974
    Individual (10 offsprings)
    Officer
    2018-12-10 ~ now
    OF - Director → CIF 0
  • 2
    Rabin, Fabienne
    Company Secretary born in September 1973
    Individual (7 offsprings)
    Officer
    2019-04-25 ~ now
    OF - Director → CIF 0
  • 3
    Barry, Christian
    Managing Director born in January 1976
    Individual (13 offsprings)
    Officer
    2019-04-25 ~ now
    OF - Director → CIF 0
    Christian Barry
    Born in January 1976
    Individual (13 offsprings)
    Person with significant control
    2019-04-25 ~ now
    PE - Ownership of shares – More than 50% but less than 75% → CIF 0
    PE - Ownership of voting rights - More than 50% but less than 75% → CIF 0
    PE - Right to appoint or remove directors → CIF 0
Ceased 2
  • 1
    Mr Joel Rabin
    Born in February 1974
    Individual (10 offsprings)
    Person with significant control
    2018-12-10 ~ 2019-04-25
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
  • 2
    Jakobsen, David Lars
    Director born in December 1958
    Individual (2 offsprings)
    Officer
    2019-04-25 ~ 2023-12-02
    OF - Director → CIF 0
parent relation
Company in focus

TELETA PHARMA HOLDINGS LIMITED

Standard Industrial Classification
64209 - Activities Of Other Holding Companies N.e.c.
Brief company account
Average Number of Employees
02022-07-01 ~ 2023-06-30
02021-07-01 ~ 2022-06-30
Fixed Assets - Investments
7,750,025 GBP2023-06-30
12,562,500 GBP2022-06-30
Fixed Assets
7,750,025 GBP2023-06-30
12,562,500 GBP2022-06-30
Debtors
Current
4,474,321 GBP2023-06-30
265,136 GBP2022-06-30
Current Assets
4,474,321 GBP2023-06-30
265,136 GBP2022-06-30
Creditors
Current, Amounts falling due within one year
-94,285 GBP2022-06-30
Net Current Assets/Liabilities
4,474,321 GBP2023-06-30
170,851 GBP2022-06-30
Total Assets Less Current Liabilities
12,224,346 GBP2023-06-30
12,733,351 GBP2022-06-30
Creditors
Non-current, Amounts falling due after one year
-5,000,000 GBP2023-06-30
-5,000,000 GBP2022-06-30
Net Assets/Liabilities
7,224,346 GBP2023-06-30
7,733,351 GBP2022-06-30
Equity
Called up share capital
700,200 GBP2023-06-30
700,200 GBP2022-06-30
200 GBP2021-07-01
Retained earnings (accumulated losses)
6,524,146 GBP2023-06-30
7,033,151 GBP2022-06-30
7,183,151 GBP2021-07-01
Profit/Loss
-509,005 GBP2022-07-01 ~ 2023-06-30
-150,000 GBP2021-07-01 ~ 2022-06-30
Equity
7,224,346 GBP2023-06-30
7,733,351 GBP2022-06-30
7,183,351 GBP2021-07-01
Profit/Loss
Retained earnings (accumulated losses)
-509,005 GBP2022-07-01 ~ 2023-06-30
-150,000 GBP2021-07-01 ~ 2022-06-30
Comprehensive Income/Expense
Retained earnings (accumulated losses)
-509,005 GBP2022-07-01 ~ 2023-06-30
-150,000 GBP2021-07-01 ~ 2022-06-30
Comprehensive Income/Expense
-509,005 GBP2022-07-01 ~ 2023-06-30
-150,000 GBP2021-07-01 ~ 2022-06-30
Issue of Equity Instruments
Called up share capital
700,000 GBP2021-07-01 ~ 2022-06-30
Issue of Equity Instruments
700,000 GBP2021-07-01 ~ 2022-06-30
Amounts Owed by Group Undertakings
Current
4,474,121 GBP2023-06-30
264,936 GBP2022-06-30
Called-up share capital (not paid)
Current
200 GBP2023-06-30
200 GBP2022-06-30
Accrued Liabilities/Deferred Income
Current
94,285 GBP2022-06-30
Creditors
Current
94,285 GBP2022-06-30
Other Remaining Borrowings
Non-current
5,000,000 GBP2023-06-30
5,000,000 GBP2022-06-30
Creditors
Non-current
5,000,000 GBP2023-06-30
5,000,000 GBP2022-06-30
Total Borrowings
5,000,000 GBP2023-06-30
5,000,000 GBP2022-06-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
200 shares2023-06-30
200 shares2022-06-30
Par Value of Share
Class 1 ordinary share
1.000002022-07-01 ~ 2023-06-30
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
700,000 shares2023-06-30
700,000 shares2022-06-30
Par Value of Share
Class 2 ordinary share
1.000002022-07-01 ~ 2023-06-30
Related profiles found in government register
  • TELETA PHARMA HOLDINGS LIMITED
    Info
    Registered number 11719162
    Old Station Road, Loughton, Essex IG10 4PL
    Private Limited Company incorporated on 2018-12-10 (6 years 7 months). The company status is Active.
    The last date of confirmation statement was made at 2024-12-09
    CIF 0
  • TELETA PHARMA HOLDINGS LIMITED
    S
    Registered number 11719162
    Old Station Road, Loughton, Essex, United Kingdom, IG10 4PL
    Limited Company in England And Wales Companies Registry, United Kingdom
    CIF 1 CIF 2
child relation
Offspring entities and appointments
Active 2
  • 1
    Haslers, Old Station Road, Loughton, Essex
    Active Corporate (4 parents, 1 offspring)
    Equity (Company account)
    5,653 GBP2023-06-30
    Person with significant control
    2019-05-22 ~ now
    CIF 1 - Ownership of shares – 75% or more → OE
    CIF 1 - Ownership of voting rights - 75% or more → OE
    CIF 1 - Right to appoint or remove directors → OE
  • 2
    PHABS PHARMA LIMITED - 2015-08-26
    C/o Haslers, Old Station Road, Loughton, Essex
    Active Corporate (5 parents, 1 offspring)
    Equity (Company account)
    3,251,025 GBP2023-06-30
    Person with significant control
    2019-05-22 ~ now
    CIF 2 - Ownership of shares – 75% or more → OE
    CIF 2 - Ownership of voting rights - 75% or more → OE
    CIF 2 - Right to appoint or remove directors → OE

qrcode

Privacy notice

Terms and conditions

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.